Research on Diagnosis and Treatment of Thyroid Nodules and Thyroid Cancer
Using Standard Care and Emerging Techniques
Led by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Updated on 2026-06-18
2500
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
This research aims to improve understanding of how thyroid nodules and thyroid cancer are diagnosed and treated. It involves patients diagnosed with or suspected to have these conditions, including those with a family risk of thyroid cancer. The study evaluates both standard medical care and new techniques as they are developed, focusing on diagnosis, therapy, and the natural history of thyroid tumors.
Participants will undergo diagnostic imaging, fine needle aspiration biopsies, surgery, and radioiodine scans or therapy as part of their care. The study also assesses the usefulness of blood tests like serum thyroglobulin for detecting tumor recurrence and evaluates individualized radioiodine treatment approaches. Tissue and blood samples will be collected for research using methods such as microscopy and molecular analysis to better understand thyroid function and disease.
During the study, participants receive routine clinical care with additional research tests performed. Blood and urine samples will be collected during different thyroid function states for genetic and molecular studies. Researchers will monitor thyroid cancer and thyroid disorders as clinically indicated, using tumor marker tracking and anatomical and functional imaging. The study includes adults and children over 6 months old and involves ongoing evaluation without a fixed end date.
CONDITIONS
Brief Title
Studies on Tumors of the Thyroid
Research Team
P
Padmasree Veeraraghavan, R.N.
J
Joanna Klubo-Gwiezdzinska, M.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Lead Sponsor
Who Can Participate
Age: 6Months - 98Years
All Genders
Eligibility Criteria
You may qualify if you...
Male or female, adults or children 6 months or older
Patients with known or suspected thyroid nodules and/or thyroid cancer
Family members at risk for thyroid cancer due to genetic susceptibility
You will not qualify if you...
Serious medical conditions restricting diagnostic testing or therapy, such as kidney failure, congestive heart failure, or active non-thyroid cancers needing treatment before thyroid cancer
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Monitoring and Standard Care
Duration - Ongoing as clinically indicated
Participants receive diagnostic imaging, biopsies, surgery, radioiodine scans or therapy, and follow-up monitoring as part of standard care. Blood and tissue samples are collected for research during various thyroid function states.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Phase I Study of 177Lu-CTR-FAPI Radioligand Therapy for Thyroid Cancer Evaluating Safety and Effectiveness
Safety and Effectiveness of a New 18F Labeled Fibroblast Activation Protein Probe for Early Tumor Detection
Including Lung, Pancreatic, Neuroendocrine, and Thyroid Cancers
Study Comparing Preoperative and Intraoperative Carbon Nanoparticle Injections in Thyroid Cancer Surgery Patients
Phase III Study Comparing Preventive Central Neck Dissection Versus No Dissection in Adults with Low-risk Papillary Thyroid Cancer
Phase 3 Trial of AL2846 Capsules Versus Placebo for Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer After VEGFR-Targeted Therapy
Phase 2 Study of Avutometinib and Defactinib for Treating RAF Dimer-Driven Radioiodine-Refractory Differentiated and Anaplastic Thyroid Cancer
Comparison of Meaning-Centered Psychotherapy and Cognitive Behavioral Therapy for Mexican Adults with Advanced Cancer
Randomized Study Comparing Online and Offline Follow-up for Adults With Papillary Thyroid Cancer After Surgery
Collecting Information on Use of Redifferentiation Medications for Radioactive Iodine-Refractory Thyroid Cancer in Routine Care
Phase 1 Study of PF-07799544 Alone or with PF-07799933 in Adults With BRAF V600 Mutation Advanced Solid Tumors
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Limited Utility of Circulating Cell-Free DNA Integrity as a Diagnostic Tool for Differentiating Between Malignant and Benign Thyroid Nodules With Indeterminate Cytology (Bethesda Category III).